Form 4 for KPTI Karyopharm Therapeutics Inc.
Accepted 2026-01-22 00:00:00 ET · period of report 2026-01-21 · accession 0001193125-26-019428 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-01-22 | 2026-01-21 | KPTI | Abate Kristin | CAO | S - Sale | $5.96 | -265 | 22.6K | -1% | -$1,579 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-21 | S | D | 265 | $5.96 | 22,580 | D | — | — |